Table 3.
BL |
TL |
||||
---|---|---|---|---|---|
Entity | Corpus | Average | σ | Average | σ |
Chemicals | BC4CHEMD | 88.46 | 0.61 | 88.98 | 0.63 |
BC5CDR | 92.82 | 0.80 | 92.20 | 0.86 | |
CRAFT | 84.98 | 1.98 | 85.80 | 1.74 | |
Disease | BC5CDR | 84.49 | 0.33 | 84.41 | 0.24 |
NCBI-disease | 87.01 | 1.17 | 87.66 | 0.86 | |
Variome | 85.75 | 2.83 | 86.69 | 3.03 | |
Species | CRAFT | 96.28 | 2.21 | 96.55 | 1.72 |
Linnaeus | 89.44 | 3.91 | 90.72 | 4.90 | |
S800 | 72.75 | 2.42 | 74.93 | 3.27 | |
Genes/proteins | BC2GM | 81.48 | 0.48 | 80.65* | 0.57 |
CRAFT | 84.46 | 6.08 | 85.50 | 4.59 | |
JNLPBA | 80.92 | 2.50 | 81.56 | 2.73 |
Note: The TL model was pre-trained on the CALBC-Small-III corpus. IC performance is derived from 5-fold cross-validation, using exact matching criteria. Statistical significance is measured through a two-tailed t-test. Bold, best scores, σ, standard deviation.
Significantly different than the BL (P ≤ 0.05).